131 related articles for article (PubMed ID: 10086813)
1. Learning from case reports: diagnostic issues in an epidemiologic study of pancreatic cancer.
Soler M; Porta M; Malats N; Guarner L; Costafreda S; Gubern JM; García-Olivares E; Andreu M; Real FX
J Clin Epidemiol; 1998 Dec; 51(12):1215-21. PubMed ID: 10086813
[TBL] [Abstract][Full Text] [Related]
2. Relative contribution of Ki-ras gene analysis and brush cytology during ERCP for the diagnosis of biliary and pancreatic diseases.
Van Laethem JL; Bourgeois V; Parma J; Delhaye M; Cochaux P; Velu T; Devière J; Cremer M
Gastrointest Endosc; 1998 Jun; 47(6):479-85. PubMed ID: 9647372
[TBL] [Abstract][Full Text] [Related]
3. The role of K-ras gene mutation analysis in EUS-guided FNA cytology specimens for the differential diagnosis of pancreatic solid masses: a meta-analysis of prospective studies.
Fuccio L; Hassan C; Laterza L; Correale L; Pagano N; Bocus P; Fabbri C; Maimone A; Cennamo V; Repici A; Costamagna G; Bazzoli F; Larghi A
Gastrointest Endosc; 2013 Oct; 78(4):596-608. PubMed ID: 23660563
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of pancreatico-biliary malignancy: detection of gene mutations in plasma and stool.
Mulcahy H; Farthing MJ
Ann Oncol; 1999; 10 Suppl 4():114-7. PubMed ID: 10436800
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic certainty and potential for misclassification in exocrine pancreatic cancer. PANKRAS I Project Investigations.
Porta M; Malats N; Piñol JL; Rifà J; Andreu M; Real FX
J Clin Epidemiol; 1994 Sep; 47(9):1069-79. PubMed ID: 7730910
[TBL] [Abstract][Full Text] [Related]
6. Identification of K-ras mutations in pancreatic juice in the early diagnosis of pancreatic cancer.
Berthélemy P; Bouisson M; Escourrou J; Vaysse N; Rumeau JL; Pradayrol L
Ann Intern Med; 1995 Aug; 123(3):188-91. PubMed ID: 7598300
[TBL] [Abstract][Full Text] [Related]
7. Validity of the hospital discharge diagnosis in epidemiologic studies of biliopancreatic pathology. PANKRAS II Study Group.
Porta M; Costafreda S; Malats N; Guarner L; Soler M; Gubern JM; García-Olivares E; Andreu M; Salas A; Corominas JM; Alguacil J; Carrato A; Rifà J; Real FX
Eur J Epidemiol; 2000 Jun; 16(6):533-41. PubMed ID: 11049097
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of p16 and K-ras mutation in pancreatic adenocarcinoma and chronic pancreatitis differential diagnosis.
Talar-Wojnarowska R; Gasiorowska A; Smolarz B; Romanowicz-Makowska H; Strzelczyk J; Janiak A; Kulig A; Malecka-Panas E
J Physiol Pharmacol; 2004 Jul; 55 Suppl 2():129-38. PubMed ID: 15608367
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of K-ras and c-erbB-2 mutations in pancreatic adenocarcinoma and chronic pancreatitis.
Talar-Wojnarowska R; Gasiorowska A; Smolarz B; Romanowicz-Makowska H; Strzelczyk J; Janiak A; Kulig A; Malecka-Panas E
Int J Gastrointest Cancer; 2005; 35(1):33-41. PubMed ID: 15722572
[TBL] [Abstract][Full Text] [Related]
10. Detection of c-Ki-ras gene codon 12 mutations from pancreatic duct brushings in the diagnosis of pancreatic tumours.
Van Laethem JL; Vertongen P; Deviere J; Van Rampelbergh J; Rickaert F; Cremer M; Robberecht P
Gut; 1995 May; 36(5):781-7. PubMed ID: 7797131
[TBL] [Abstract][Full Text] [Related]
11. K-ras mutations in DNA extracted from the plasma of patients with pancreatic carcinoma: diagnostic utility and prognostic significance.
Castells A; Puig P; Móra J; Boadas J; Boix L; Urgell E; Solé M; Capellà G; Lluís F; Fernández-Cruz L; Navarro S; Farré A
J Clin Oncol; 1999 Feb; 17(2):578-84. PubMed ID: 10080602
[TBL] [Abstract][Full Text] [Related]
12. K-ras point mutations in the supernatants of pancreatic juice and bile are reliable for diagnosis of pancreas and biliary tract carcinomas complementary to cytologic examination.
Yamashita K; Kida Y; Shinoda H; Kida M; Okayasu I
Jpn J Cancer Res; 1999 Feb; 90(2):240-8. PubMed ID: 10189896
[TBL] [Abstract][Full Text] [Related]
13. Mutational activation of K-ras in nonneoplastic exocrine pancreatic lesions in relation to cigarette smoking status.
Berger DH; Chang H; Wood M; Huang L; Heath CW; Lehman T; Ruggeri BA
Cancer; 1999 Jan; 85(2):326-32. PubMed ID: 10023699
[TBL] [Abstract][Full Text] [Related]
14. Early detection of pancreatic cancer in patients with chronic pancreatitis: diagnostic utility of a K-ras point mutation in the pancreatic juice.
Queneau PE; Adessi GL; Thibault P; Cléau D; Heyd B; Mantion G; Carayon P
Am J Gastroenterol; 2001 Mar; 96(3):700-4. PubMed ID: 11280537
[TBL] [Abstract][Full Text] [Related]
15. Association between coffee drinking and K-ras mutations in exocrine pancreatic cancer. PANKRAS II Study Group.
Porta M; Malats N; Guarner L; Carrato A; Rifà J; Salas A; Corominas JM; Andreu M; Real FX
J Epidemiol Community Health; 1999 Nov; 53(11):702-9. PubMed ID: 10656099
[TBL] [Abstract][Full Text] [Related]
16. A new strategy for the application of CA19-9 in the differentiation of pancreaticobiliary cancer: analysis using a receiver operating characteristic curve.
Kim HJ; Kim MH; Myung SJ; Lim BC; Park ET; Yoo KS; Seo DW; Lee SK; Min YI
Am J Gastroenterol; 1999 Jul; 94(7):1941-6. PubMed ID: 10406263
[TBL] [Abstract][Full Text] [Related]
17. K-ras mutation in focal proliferative lesions of human pancreas.
Terhune PG; Phifer DM; Tosteson TD; Longnecker DS
Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):515-21. PubMed ID: 9641496
[TBL] [Abstract][Full Text] [Related]
18. Detection of pancreatic carcinoma: diagnostic value of K-ras mutations in circulating DNA from serum.
Theodor L; Melzer E; Sologov M; Idelman G; Friedman E; Bar-Meir S
Dig Dis Sci; 1999 Oct; 44(10):2014-9. PubMed ID: 10548352
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of K-ras gene mutation at codon 12 in bile for diagnosing biliary strictures.
Ito R; Tamura K; Ashida H; Nishiwaki M; Nishioka A; Yamamoto Y; Furuyama JI; Utsunomiya J
Int J Oncol; 1998 May; 12(5):1019-23. PubMed ID: 9538122
[TBL] [Abstract][Full Text] [Related]
20. K-ras mutations in duodenal aspirate without secretin stimulation for screening of pancreatic and biliary tract carcinoma.
Watanabe H; Ha A; Hu YX; Ohtsubo K; Yamaguchi Y; Motoo Y; Okai T; Toya D; Tanaka N; Sawabu N
Cancer; 1999 Oct; 86(8):1441-8. PubMed ID: 10526271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
